#HDaccess - Twitter Hashtag

Mohamad A Hussain MD @ma_hussainMD

about 1 year ago

Kicking off ⁦@VASAMD⁩ 2025 Practicum on #HDAccess! Fantastic program for hands on experience & great turnout

2

11

0

866

Mohamad A Hussain MD @ma_hussainMD

almost 2 years ago

Results of the @humacyte V007 Trial are out! #ATEV (Acellular Tissue Engineered Vessel) was superior to #AVF in #ESKD patients on #HD, particularly in high-risk patients: #females, #diabetics & #obese. Infection similary low in both groups. Exciting potential option in #HDaccess

ma_hussainMD's tweet photo. Results of the @humacyte V007 Trial are out! #ATEV (Acellular Tissue Engineered Vessel) was superior to #AVF in #ESKD patients on #HD, particularly in high-risk patients: #females, #diabetics & #obese. Infection similary low in both groups. Exciting potential option in #HDaccess https://t.co/5Yr3dm3j4l

Joel M. Topf, MD FACP

@kidney_boy

almost 2 years ago

Next up Mohamad Hussain on an artificial vessel for AV fistula. Acellular Tissue Engineered Vessel (ATEV) More durable and more infection resistant than current grafts #KidneyWk

kidney_boy's tweet photo. Next up Mohamad Hussain on an artificial vessel for AV fistula.
Acellular Tissue Engineered Vessel (ATEV)

More durable and more infection resistant than current grafts

#KidneyWk https://t.co/c0KL7oTOsf

1

20

3

9K

2

27

6

4

11K

Patrick Heindel, MD, MPH @PatrickHeindel

almost 4 years ago

Very excited to share our ongoing work to better understand #HDaccess - great discussion about clinical implications and upcoming improvements to our PREDICT-AVF calculator @CKeithOzaki @ma_hussainMD 📲 https://t.co/2jZ2siGpWh details in upcoming issue of @npjDigitalMed

BWH Vascular Surgery @BrighamVascular

almost 4 years ago

Congrats to @BrighamSurgery resident @PatrickHeindel for a fantastic presentation on Recurrent Interventions after Radiocephalic Fistula Creation at the 2022 @NewEnglandVasc Annual Meeting!